Skinvisible, Inc. (SKVI) Set to Repeat Olympic Performance in 2018 with DermSafe

• Targeting $80 billion global skincare and dermatology market
• Revenues to be derived from royalties and other licensing fees
• DermSafe sales have taken off in Greater China
• Pending merger will expand product offerings

Among the winners at the 2016 Summer Olympics in Rio was DermSafe® from Skinvisible’s (OTCQB: SKVI) subsidiary, Kintari. Donated to Team Canada, the non-alcohol hand sanitizing lotion offered protection from pathogens to athletes during the Olympic Games. Now, with the Winter Olympics to be held in South Korea from February 8-25, the need is more pressing. Reported outbreaks of the flu have increased dramatically this year, according to the Centers for Disease Control and Prevention (http://ibn.fm/2rjXw). For the first time since it began monitoring flu patterns, the CDC has reported widespread flu activity in every part of the continental U.S. There is no doubt that antiseptics like DermSafe, which inhibit the spread of contact infections, will take center stage again. There’s a lot at stake. Influenza kills at least 12,000 Americans every year.

The main curse this season is the particularly malevolent influenza virus H3N2. It is the most dominant strain not only in the U.S. but in Canada and the UK. The virus, experts believe, is mainly transmitted through the air by droplets formed when infected persons cough, sneeze or talk. These droplets land on hard surfaces like door knobs and as soon as one touches it they have just transferred the virus to their hands. With over 90 percent of all germs coming into one’s body from their hands, it is very important to wash them regularly. Regular use of an alcohol hand sanitizer will work as a replacement to hand washing, but it, too, is only immediate and offers no long term protection. Independent studies verify that DermSafe, when applied to the hands, offers a continuous long term kill on bacteria and viruses tested including the H3N2 virus. Consequently, a hand sanitizer like DermSafe is a vital safeguard against the spread of such germs.

DermSafe incorporates Skinvisible’s proprietary Invisicare® drug delivery technology, which is effective at bonding active ingredients to the skin for up to four hours and longer. Invisicare is non-occlusive; it allows normal skin respiration and perspiration while moisturizing and protecting against exposure from a wide variety of environmental irritants. When topically applied, products formulated with Invisicare adhere to the skin’s outer layers, forming a protective bond, resisting wash-off and delivering targeted levels of therapeutic or cosmetic skincare agents to the skin. This allows enhanced delivery performance for a variety of topicals resulting in improved efficacy, longer duration of action, reduced irritation and lower dosage of active agent required. The “invisible” polymer compositions that make up Invisicare wear off as part of the natural exfoliation process that removes the skin’s outer layer of cells.

Having made its debut in Rio, DermSafe is set for a repeat performance at the 2018 Winter Olympics in South Korea. Skinvisible has donated over 1,000 bottles of DermSafe to the Canadian Olympic team. DermSafe provides a long-lasting protective barrier that binds to the skin and actively combats the spread of germs between people and between people and hard surfaces. Composed of four percent chlorhexidine gluconate (CHG), the same active ingredient found in soaps used in hospital operating rooms, DermSafe offers long-term protection and destroys both gram-negative and gram-positive bacteria and viruses. It has proven effective against a host of infectious germs, including Methicillin-resistant Staphylococcus aureus (MRSA) and Escherichia coli (E. coli). Sales of DermSafe have already taken off in China, and the product will be marketed throughout Hong Kong, Macau, Taiwan, Singapore, Malaysia and Thailand.

China, with a population of over 1.6 billion people, exhibits a strong demand for American-made products, driven both by the growth of the middle class in large cities and an increased desire for high quality products. Last year, China imported $2.7 billion in personal care products, and around 69 percent of Chinese women, in one recent survey, said they are in the market for such products and would buy them from online stores, spending an average of $1,800 a year. As well as DermSafe, Kintari offers a line of anti-aging products that includes day cream, night cream, hand and body lotion, and sunscreen. Skinvisible’s foray into Greater China is in line with its strategy of driving Kintari-branded product sales through subsidiaries in the U.S. and Canada and international distribution and licensing agreements.

Along with Skinvisible’s cosmeceutical and over-the-counter products, Skinvisible has signed a letter of intent with Quoin Pharmaceuticals Inc. to merge the two companies and to pursue additional medical conditions, such as post-surgical pain and PTSD with suicidal thoughts in the military.

For more information, visit the company’s website at www.Skinvisible.com

Let us hear your thoughts: Skinvisible, Inc. Message Board

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php